Publications
Original Article
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival
T Cell Function & Therapy
2011
Authors:
Paulson K.G., Iyer J. G., Tegeder A. R., Thibodeau R., Schelter J., Koba S., Schrama D., Simonson W. T., Lemos B. D., Byrd D. R., Koelle D. M., Galloway D. A., Leonard J. H., Madeleine M. M., Argenyi Z. B., Disis M. L., Becker J. C., Cleary M. A., Nghiem P.
Journal:
Journal of Clinical Oncology
Volume:
29(12)
Page:
1539-46
Original Article
Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells
Tumor Microenvironment
2011
Authors:
Lu H, Yang Y, Gad E, Wenner CA, Chang A, Larson ER, Dang Y, Martzen M, Standish LJ, Disis ML.
Journal:
Clinical Cancer Research
Volume:
17(1)
Page:
67-76
Review Article
ELISpot for measuring human immune responses to vaccines
Measuring Human Immunity
2011
Authors:
Slota M, Lim JB, Dang Y, Disis ML.
Journal:
Expert Review of Vaccine
Volume:
10(3)
Page:
299-306
Original Article
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer
Cancer Vaccines
2011
Authors:
Hahn T., Bradley-Dunlop D. J., Hurley L. H., Von-Hoff D., Gately S., Disis M. L., Lu H. L., Penichet M. L., Besselsen D. G., Cole B. B., Meeuwsen T., Walker E., Akporiaye E. T.
Journal:
BMC Cancer
Volume:
11
Page:
471
Review Article
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
Measuring Human Immunity
2011
Authors:
Disis, M.L..
Journal:
Cancer Immunology Immunotherapy
Volume:
60(3)
Page:
433-43
Review Article
TNM staging in colorectal cancer: T is for T cell and M is for memory
2011
Authors:
Broussard EK, Disis ML.
Journal:
Journal of Clinical Oncology
Volume:
29(6)
Page:
601-3
Review Article
Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept
Cancer Vaccines
2011
Authors:
0'Meara M., Disis M.L.
Journal:
OMICS
Volume:
15(9)
Page:
579-88
Review Article
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
2011
Authors:
Butterfield L.H., Palucka A.K., Britten C.M., Dhodapkar M.V., Hakansson L., Janetzki S., Kawakami, Y., Kleen T.O., Lee P.P., Maccalli C., Maecker H.T., Maino V.C., Maio M., Malyguine A., Masucci G., Pawelec G., Potter D.M., Rivoltini L.M., Salazar L.G., Schendel D.G., Slingluff C.L., Song W., Stroncek D.F., Tahara H., Thurin M., Trinchieri G., van Der Burg S.H., Whiteside T.L., Wigginton J.M., Marincola F.M., Fox B.A., Disis M.L.
Journal:
Clinical Cancer Research
Volume:
17(10)
Page:
3064-76
Original Article
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy
Tumor Microenvironment
2011
Authors:
Lu H., Yang Y., Gad E., Inatsuka C., Wenner C. A., Disis M. L., Standish L. J.
Journal:
Clinical Cancer Research
Volume:
17(21)
Page:
6742-53
Review Article
The ultimate in cancer chemoprevention: cancer vaccines
Cancer Vaccines
2010
Authors:
Disis ML.
Journal:
Cancer Prevention Research
Volume:
3(4)
Page:
406=9